KP Tissue (TSE:KPT - Get Free Report) had its price target boosted by National Bankshares from C$9.50 to C$10.00 in a research report issued on Thursday,BayStreet.CA reports. The brokerage presently has a "sector perform" rating on the stock. National Bankshares' price objective points to a potential upside of 4.71% from the company's previous close.
A number of other research analysts also recently weighed in on the company. TD Securities increased their price target on KP Tissue from C$8.00 to C$9.00 and gave the company a "hold" rating in a research note on Thursday, May 22nd. Desjardins increased their price target on KP Tissue from C$9.50 to C$10.00 and gave the company a "hold" rating in a research note on Thursday.
Get Our Latest Analysis on KPT
KP Tissue Stock Performance
KPT traded up C$0.05 during mid-day trading on Thursday, reaching C$9.55. The stock had a trading volume of 12,300 shares, compared to its average volume of 16,224. The firm's fifty day simple moving average is C$9.12 and its two-hundred day simple moving average is C$8.48. The stock has a market capitalization of C$95.44 million, a P/E ratio of 14.95, a P/E/G ratio of -0.88 and a beta of 0.37. KP Tissue has a 52 week low of C$7.54 and a 52 week high of C$9.64.
KP Tissue Company Profile
(
Get Free Report)
KP Tissue Inc, through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through two segments, Consumer and Away-From-Home. It offers bathroom and facial tissues, paper towels, and napkins.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider KP Tissue, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KP Tissue wasn't on the list.
While KP Tissue currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.